Skip to Content
Merck

Prediction of the stability of imipenem in intravenous mixtures.

Chemical & pharmaceutical bulletin (2012-11-06)
Miyako Yoshida, Yuko Takasu, Kaori Shimizu, Keiichi Asahara, Takahiro Uchida
ABSTRACT

The purpose of this study was to predict the stability of imipenem in a mixed infusion. The hydrolysis of imipenem in aqueous solution was found to be accelerated by pH, and by increasing concentrations of sodium bisulfite (SBS) and L-cysteine. Equations were derived for the degradation rate constants (k(obs)) of pH, SBS and L-cysteine and fractional rate constants were estimated by nonlinear least-squares method (quasi-Newton method using the solver in Microsoft Excel) at 25°C. The activation energy (Ea) and frequency factor (A) were calculated using the Arrhenius equation. The pH of the mixed infusion was estimated using the pH characteristic (PHC) curve. From these results, an equation was derived giving the residual ratio (%) of imipenem at any time after mixing an infusion containing SBS and/or L-cysteine at any temperature and at pH 4.0-10.0. A high correlation was shown to exist between the estimated and determined residual ratios (%).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium bisulfite, JIS special grade, 64.0-67.4% SO2 basis
Sigma-Aldrich
Sodium bisulfite, ACS reagent
Sigma-Aldrich
Sodium bisulfite solution, purum, ~40%
Sigma-Aldrich
Sodium bisulfite, anhydrous, free-flowing, Redi-Dri, ACS reagent